Optimizing Post-Kasai Management in Biliary Atresia: Balancing Native Liver Survival and Transplant Timing

Omid Madadi-Sanjani; Marie Uecker; Gordon Thomas; Lutz Fischer; Bianca Hegen; Jochen Herrmann; Konrad Reinshagen; Christian Tomuschat

doi:10.1055/a-2507-8270

European Journal of Pediatric Surgery, Table of Contents

Eur J Pediatr Surg 2025; 35(04): 261-268
DOI: 10.1055/a-2507-8270

Review Article

Optimizing Post-Kasai Management in Biliary Atresia: Balancing Native Liver Survival and Transplant Timing

Omid Madadi-Sanjani

¹Department of Transplant Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

,

Marie Uecker

²Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany

,

Gordon Thomas

³Department of Surgery, Children's Hospital at Westmead, Sydney Medical School, University of Sydney, New South Wales, Australia

,

Lutz Fischer

¹Department of Transplant Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

,

Bianca Hegen

⁴Department of Pediatric Gastroenterology and Hepatology, University Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

,

Jochen Herrmann

⁵Department of Pediatric Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

,

Konrad Reinshagen

⁶Department of Pediatric Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

,

Christian Tomuschat

⁶Department of Pediatric Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

› Author Affiliations

Abstract

Background Kasai procedure (KPE) is a palliative intervention in infants with biliary atresia (BA) aiming to restore biliary drainage. While the measure of success in BA is the post-Kasai native liver survival (NLS), BA remains the most frequent indication for liver transplantation in children. While a considerable amount of children fail to clear their jaundice following KPE, resulting in early liver failure and transplantation, some children become jaundice-free after “successful” KPE. However, sequelae of chronic liver disease might affect those children, becoming a later risk for NLS. While liver transplantation is inevitable in the majority of children, various salvage procedures have been recently described to maintain NLS. This article provides a comprehensive overview of procedures performed after KPE to prolong NLS in BA patients from early childhood to late adulthood and discusses their indications and limitations.

Methods A literature-based search for surgical and radiological interventions performed in BA patients after KPE to prolong NLS (salvage procedures) was performed using PubMed. Data from case reports, retrospective studies, and registries were included.

Results Fifteen studies included 794 patients who underwent post-KPE salvage procedures. The Oxford Centre for Evidence-Based Medicine levels were IIc to IV.

Interventions included redo-Kasai's (n = 710) for cessation of bile flow post-KPE, surgical and radiological procedures (n = 14) for bile lakes, and recurrent cholangitis, shunt surgery (n = 49), and transjugular intrahepatic portosystemic shunt (n = 21) for portal hypertension in BA patients. Age at the time of salvage interventions varied considerably, including redo-Kasai's at 27 days of life and percutaneous biliary interventions in a 35-year-old.

Conclusion Salvage procedures can maintain NLS after KPE in BA patients with disease sequelae. However, indications remain scarce and liver transplantation is ultimately unavoidable in the majority of patients. While redo-Kasai numbers are globally decreasing with the advances in liver transplantation, procedures for bile lakes and portal hypertension can be viable options for patients with complications but otherwise stable liver function. Discussion on those procedures should be held by multidisciplinary expert teams, involving pediatric hepatologists, pediatric surgeons, and transplant surgeons to elaborate on the potential of maintaining NLS or proceeding with transplantation.

Keywords

biliary atresia - cholangitis - portal hypertension - redo procedure - shunt

Full Text

References

References
1 Pakarinen MP, Rintala RJ. Surgery of biliary atresia. Scand J Surg 2011; 100 (01) 49-53
2 Fanna M, Masson G, Capito C. et al. Management of biliary atresia in France 1986 to 2015: long-term results. J Pediatr Gastroenterol Nutr 2019; 69 (04) 416-424
3 Davenport M, Ong E, Sharif K. et al. Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg 2011; 46 (09) 1689-1694
4 de Vries W, de Langen ZJ, Groen H. et al; Netherlands Study Group of Biliary Atresia and Registry (NeSBAR). Biliary atresia in the Netherlands: outcome of patients diagnosed between 1987 and 2008. J Pediatr 2012; 160 (04) 638-644.e2
5 Bijl EJ, Bharwani KD, Houwen RHJ, de Man RA. The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review. Neth J Med 2013; 71 (04) 170-173
6 Hukkinen M, Kerola A, Lohi J. et al. Treatment policy and liver histopathology predict biliary atresia outcomes: results after national centralization and protocol biopsies. J Am Coll Surg 2018; 226 (01) 46-57.e1
7 Madadi-Sanjani O, Fortmann D, Rolle U. et al. Centralization of biliary atresia: has Germany learned its lessons?. Eur J Pediatr Surg 2022; 32 (03) 233-239
8 Wildhaber BE, Majno P, Mayr J. et al. Biliary atresia: Swiss national study, 1994-2004. J Pediatr Gastroenterol Nutr 2008; 46 (03) 299-307
9 Baker A, Frauca Remacha E, Torres Canizales J. et al. Current practices on diagnosis, prevention and treatment of post-transplant lymphoproliferative disorder in pediatric patients after solid organ transplantation: results of ERN TransplantChild Healthcare Working Group Survey. Children (Basel) 2021; 8 (08) 661
10 Le M, Reinshagen K, Tomuschat C. Systematic review: The quality of life of patients with biliary atresia. J Pediatr Surg 2022; 57 (12) 934-946
11 Davenport M. Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change?. Pediatr Surg Int 2017; 33 (12) 1263-1273
12 Burns J, Davenport M. Adjuvant treatments for biliary atresia. Transl Pediatr 2020; 9 (03) 253-265
13 Fligor SC, Hirsch TI, Tsikis ST, Adeola A, Puder M. Current and emerging adjuvant therapies in biliary atresia. Front Pediatr 2022; 10: 1007813
14 Nio M, Sasaki H, Tanaka H, Okamura A. Redo surgery for biliary atresia. Pediatr Surg Int 2013; 29 (10) 989-993
15 Nakamura H, Kawano T, Yoshizawa K. et al. Long-term follow-up for anicteric survival with native liver after redo Kasai: a first report. J Pediatr Surg 2016; 51 (12) 2109-2112
16 Mendoza MM, Chiang JH, Lee SY. et al. Reappraise the effect of redo-Kasai for recurrent jaundice following Kasai operation for biliary atresia in the era of liver transplantation. Pediatr Surg Int 2012; 28 (09) 861-864
17 Ji Y, Zhang X, Chen S. et al. Medium-term outcomes after laparoscopic revision of laparoscopic Kasai portoenterostomy in patients with biliary atresia. Orphanet J Rare Dis 2021; 16 (01) 193
18 Bondoc AJ, Taylor JA, Alonso MH. et al. The beneficial impact of revision of Kasai portoenterostomy for biliary atresia: an institutional study. Ann Surg 2012; 255 (03) 570-576
19 Urahashi T, Ihara Y, Sanada Y. et al. Effect of repeat Kasai hepatic portoenterostomy on pediatric live-donor liver graft for biliary atresia. Exp Clin Transplant 2013; 11 (03) 259-263
20 Ginström DA, Hukkinen M, Kivisaari R, Pakarinen MP. Biliary atresia-associated cholangitis: the central role and effective management of bile lakes. J Pediatr Gastroenterol Nutr 2019; 68 (04) 488-494
21 Yang XJ, Dong XH, Chen SY. et al. Application of multiple Roux-en-Y hepaticojejunostomy reconstruction by formation of bile hilar duct lake in the operation of hilar cholangiocarcinoma. World J Clin Cases 2020; 8 (01) 68-75
22 Gohda Y, Uchida H, Hinoki A. et al. Laparoscopic internal intestinal drainage of bile lakes in a patient with recurrence of jaundice after laparoscopic revision of Kasai portoenterostomy for biliary atresia: a case report. Asian J Endosc Surg 2023; 16 (02) 275-278
23 Onishi Y, Shimizu H, Ohno T. et al. Percutaneous transhepatic biliary intervention in adult biliary atresia patients after Kasai portoenterostomy. JPGN Rep 2022; 3 (02) e206
24 Guérin F, Charre L, Jasienski S. et al. The efficacy of surgical shunts to treat severe portal hypertension after a Kasai procedure for biliary atresia. J Pediatr Surg 2019; 54 (03) 531-536
25 Shimizu T, Shun A, Thomas G. Portosystemic shunt for portal hypertension after Kasai operation in patients with biliary atresia. Pediatr Surg Int 2021; 37 (01) 101-107
26 Martínez-Rodrigo JJ, Boukhoubza A, Enguix DP. et al. Feasibility and outcomes of transjugular intrahepatic portosystemic shunts in infants. Pediatr Radiol 2023; 53 (05) 953-962
27 Paramesh AS, Husain SZ, Shneider B. et al. Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature. Pediatr Transplant 2003; 7 (02) 157-162
28 Chlapoutaki CE, Franchi-Abella S, Habes D, Pariente D. Custom-made covered transjugular intrahepatic portosystemic shunt (TIPS) in an infant with trisomy 22 and biliary atresia. Pediatr Radiol 2009; 39 (07) 739-742
29 Ghannam JS, Cline MR, Hage AN. et al. Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience. Pediatr Radiol 2019; 49 (01) 128-135
30 Tanaka H. Advances in pediatric liver transplantation from the pediatric surgeon's perspective. Pediatr Surg Int 2023; 39 (01) 253
31 Superina R. Biliary atresia and liver transplantation: results and thoughts for primary liver transplantation in select patients. Pediatr Surg Int 2017; 33 (12) 1297-1304
32 Lemoine CP, LeShock JP, Brandt KA, Superina R. Primary liver transplantation vs. transplant after kasai portoenterostomy for infants with biliary atresia. J Clin Med 2022; 11 (11) 3012
33 Sanha V, Franzini TA, Junior WF, Kalil AN. Are the post-transplant outcomes of Kasai's early failure and late failure comparable to the primary liver transplantation?. Cureus 2023; 15 (12) e51424
34 Ziogas IA, Ye F, Zhao Z. et al. Mortality determinants in children with biliary atresia awaiting liver transplantation. J Pediatr 2021; 228: 177-182